Ligand Pharmaceuticals (LGND)
NASDAQ: LGND
· Real-Time Price · USD
150.89
-2.90 (-1.89%)
At close: Aug 15, 2025, 3:59 PM
151.08
0.13%
After-hours: Aug 15, 2025, 04:10 PM EDT
Ligand Pharmaceuticals Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -132.62M | -4.03M | 45.24M | 42.14M | 96.34M | 52.15M | 16.48M | 27.16M | 23.97M | -33.36M | -21.29M | -7.97M | 23.65M | 57.14M | 68.31M | 47.89M | 39.25M |
Depreciation & Amortization | 34.61M | 34.51M | 34.81M | 36.06M | 35.77M | 35.64M | 37.86M | 42.82M | 46.85M | 51.37M | 53.18M | 52.29M | 51.5M | 50.95M | 50.81M | 42.75M | 34.68M |
Stock-Based Compensation | 52.65M | 52.15M | 50.35M | 31M | 27.15M | 25.74M | 49.17M | 54.88M | 57.17M | 60.28M | 41.55M | 38.7M | 39.42M | 38.78M | 38.35M | 36.34M | 33.48M |
Other Working Capital | -10.94M | -5.46M | -30.25M | -31.39M | -17.89M | -16.23M | -1.07M | 12.41M | -2.06M | 2.04M | 13.86M | -2.58M | -10.25M | -27.95M | -10.99M | 3.36M | 15.71M |
Other Non-Cash Items | 178.73M | 74.19M | 15.98M | 18.49M | -92.26M | -41.26M | -69.73M | -83.44M | -77.15M | -26.84M | 34.6M | 29.19M | 4.58M | -7.29M | -32.36M | -13.14M | -11.39M |
Deferred Income Tax | -44.19M | -15.8M | 1.83M | 11.82M | 22.49M | 11.7M | 53.05M | 32.4M | 45.66M | 20.72M | -25.96M | -11.78M | -12.39M | -8.62M | -7.97M | -19.93M | -21.04M |
Change in Working Capital | -1.81M | 11.6M | -15.99M | -36.19M | -34.06M | -34.4M | 8.16M | 34M | 23.29M | 65.68M | 29.94M | 11.12M | 13.3M | -52.16M | -65.45M | -49.49M | -26.56M |
Operating Cash Flow | 52.81M | 96.95M | 76.54M | 47.66M | 34.32M | 49.58M | 94.98M | 107.83M | 119.79M | 137.85M | 112.02M | 111.56M | 120.06M | 78.8M | 51.69M | 44.41M | 48.42M |
Capital Expenditures | -17.31M | -17.2M | -67.23M | -53.48M | -51.54M | -53.85M | -4.28M | -9.08M | -15.46M | -17.92M | -18.95M | -15.43M | -13.64M | -12.16M | -14.43M | -14.69M | -10.69M |
Cash Acquisitions | -91M | -92M | -172.2M | -101.65M | -26.65M | -25.65M | -25.64M | n/a | n/a | -750K | -256K | -256K | -256K | 494K | -355.97M | -368.18M | -383.32M |
Purchase of Investments | -185.53M | -203.79M | -126.34M | -139.85M | -164.53M | -126.76M | -119.44M | -101.74M | -52.9M | -51.23M | -103.48M | -123.66M | -147.37M | -181.32M | -202.41M | -181.93M | -327.3M |
Sales Maturities Of Investments | 257.81M | 262.5M | 277.22M | 207.19M | 216.93M | 194.17M | 141.27M | 141.5M | 129.39M | 234.39M | 259.15M | 238.47M | 238.12M | 221.34M | 249.81M | 592.11M | 703.16M |
Other Investing Acitivies | -191.78M | -185.99M | -119.59M | -75.53M | -213K | 418K | -599K | -688K | -738K | 117.89M | 117.48M | 100.99M | 99.94M | -22.46M | -17.62M | -3.21M | -15M |
Investing Cash Flow | -135M | -143.66M | -115.33M | -88.32M | -26.01M | -11.68M | -8.68M | 30M | 60.29M | 163.62M | 135.19M | 97.8M | 79.29M | 30.52M | -315.97M | 34.32M | -11.77M |
Debt Repayment | -27K | -25K | -19K | 17K | -76.85M | -76.85M | -76.87M | -114.54M | -97.61M | -260.96M | -260.95M | -225.68M | -215.69M | -164.95M | -193.5M | -195.21M | -146.4M |
Common Stock Repurchased | n/a | -3.08M | -3.33M | -3.44M | -3.47M | -392K | -2.35M | -2.35M | -2.37M | -8.24M | -24.46M | -24.37M | -24.31M | -24.35M | -10.61M | -10.61M | -10.61M |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 51.51M | 72.66M | 60.95M | 30.5M | 30.11M | 17.93M | 7.07M | 737K | -7.88M | -14.93M | -5.48M | -402K | -853K | 27.19M | 28.75M | 27.14M | 28.23M |
Financial Cash Flow | 80.27M | 97.24M | 82.17M | 30.36M | -46.95M | -59.95M | -70.56M | -114.66M | -106.34M | -275.99M | -266.53M | -226.08M | -216.55M | -137.76M | -169.45M | -172.78M | -122.88M |
Net Cash Flow | -2.1M | 49.35M | 43.76M | -10.31M | -38.63M | -22.05M | 15.74M | 23.16M | 73.73M | 25.48M | -19.31M | -16.73M | -17.2M | -28.44M | -433.68M | -93.88M | -86.06M |
Free Cash Flow | 35.51M | 79.75M | 9.31M | -5.82M | -17.22M | -4.27M | 90.71M | 98.75M | 104.33M | 119.93M | 93.07M | 96.13M | 106.42M | 66.63M | 37.27M | 29.72M | 37.73M |